Talis Biomedical Corporation: Business Overview, Financials & Competitive Analysis
Talis Biomedical Corporation scores 2/10 on the AskCyborg Cyborg Score (Challenged). A shell company in distress exploring strategic alternatives with uncertain viability as a standalone entity. The company has ceased significant operations and is exploring strategic alternatives. It trades near delisting thresholds with minimal revenue generation, negative cash flow, and requires restructuring to survive. Recent reverse stock splits and shareholder.
What is Talis Biomedical Corporation's industry? Talis Biomedical Corporation (talisbio.com) operates in Medical Devices / Molecular Diagnostics. AskCyborg classifies Talis Biomedical Corporation under Medical Devices / Molecular Diagnostics in its company registry.
Talis Biomedical is a molecular diagnostics company that previously developed point-of-care testing systems for infectious diseases. The company is currently evaluating strategic alternatives including acquisition, me...
Cyborg Score thesis
A shell company in distress exploring strategic alternatives with uncertain viability as a standalone...
Read the full analyst-debate transcript →Get the Latest Talis Biomedical Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeTalis Biomedical Corporation Overview
Pro stress-test →Talis Biomedical is a molecular diagnostics company that previously developed point-of-care testing systems for infectious diseases. The company is currently evaluating strategic alternatives including acquisition, merger, or restructuring as it has minimal active operations.
Strategic Profile
Pro stress-test →Once positioned as an innovator in molecular testing with its Talis One® System for rapid infectious disease diagnostics, the company now focuses on financial restructuring and strategic repositioning. The company maintains liquidity through cash reserves but faces operational challenges reflected in its penny-stock status and delisting risks.
Competitive Landscape
Pro stress-test →Talis competes in the molecular diagnostics space with established players like Abbott Diagnostics and Quidel. However, with minimal operations, it is no longer an active competitor. The market leader position has shifted to larger, better-funded diagnostic companies.
Industry Context
Talis Biomedical Corporation operates in Medical Devices / Molecular Diagnostics.
Key facts
Founded: 2013 · Headquarters: Chicago, Illinois · Revenue: $0 · Market cap: $15.9M